Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SRXH SRX Health Solutions Inc.
- Stocks
- Consumer Defensive
- NYSEAMERICAN: SRXH
Price (delayed)
$0.475
Market cap
$1.15M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.1
Enterprise value
$565,452
Better Choice Company Inc. operates as an animal health and wellness company. Its products portfolio includes naturally formulated kibble and canned dog and cat foods, freeze-dried raw dog foods and
Highlights
SRXH's EPS has surged by 100% year-on-year and by 100% since the previous quarter
The net income has soared by 99% YoY and by 99% QoQ
The company's equity has surged by 190% YoY but it fell by 16% QoQ
The quick ratio has soared by 133% YoY but it has decreased by 14% QoQ
Key stats
What are the main financial stats of SRXH
Market
Valuations
Earnings
Shares outstanding
2.42M
Market cap
$1.15M
Enterprise value
$565,452
Price to earnings (P/E)
N/A
Price to book (P/B)
0.11
Price to sales (P/S)
0.02
EV/EBIT
1.84
EV/EBITDA
1.29
EV/Sales
0.02
Revenue
$34.98M
Gross profit
$12.99M
Operating income
-$5.97M
Net income
-$168,000
EBIT
$308,000
EBITDA
$438,000
Free cash flow
-$4.4M
Per share
Balance sheet
Liquidity
EPS
-$0.1
EPS diluted
-$0.1
Free cash flow per share
-$2.72
Book value per share
$4.47
Revenue per share
$21.65
TBVPS
$9.53
Total assets
$15.8M
Total liabilities
$7.15M
Debt
$2.48M
Equity
$8.65M
Working capital
$7.85M
Debt to equity
0.29
Current ratio
2.1
Quick ratio
1.49
Net debt/EBITDA
-1.34
Margins
Efficiency
Dividend
EBITDA margin
1.3%
Gross margin
37.1%
Net margin
-0.5%
Operating margin
-17.1%
Return on assets
-1.1%
Return on equity
-2.8%
Return on invested capital
6.5%
Return on capital employed
3.6%
Return on sales
0.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SRXH stock price
How has the SRX Health Solutions stock price performed over time
Intraday
-16.67%
1 week
-30.95%
1 month
-74.6%
1 year
-90.02%
YTD
-79.79%
QTD
-72.38%
Financial performance
How have SRX Health Solutions's revenue and profit performed over time
Revenue
$34.98M
Gross profit
$12.99M
Operating income
-$5.97M
Net income
-$168,000
Gross margin
37.1%
Net margin
-0.5%
SRXH's net margin has surged by 99% year-on-year and by 99% since the previous quarter
The net income has soared by 99% YoY and by 99% QoQ
SRX Health Solutions's operating income has surged by 72% YoY and by 65% QoQ
The operating margin has soared by 69% year-on-year and by 66% since the previous quarter
Price vs fundamentals
How does SRXH's price correlate with its fundamentals
Growth
What is SRX Health Solutions's growth rate over time
Valuation
What is SRX Health Solutions stock price valuation
P/E
N/A
P/B
0.11
P/S
0.02
EV/EBIT
1.84
EV/EBITDA
1.29
EV/Sales
0.02
SRXH's EPS has surged by 100% year-on-year and by 100% since the previous quarter
The company's equity has surged by 190% YoY but it fell by 16% QoQ
The price to book (P/B) is 92% lower than the last 4 quarters average of 1.4
SRXH's price to sales (P/S) is 80% lower than its last 4 quarters average of 0.1
SRXH's revenue is down by 9% year-on-year but it is up by 4.3% since the previous quarter
Efficiency
How efficient is SRX Health Solutions business performance
The ROIC has soared by 104% YoY and by 102% QoQ
SRXH's return on sales has surged by 102% since the previous quarter and by 102% year-on-year
SRXH's ROE has soared by 99% from the previous quarter and by 98% YoY
The company's return on assets has surged by 99% QoQ and by 99% YoY
Dividends
What is SRXH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SRXH.
Financial health
How did SRX Health Solutions financials performed over time
The total assets is 121% greater than the total liabilities
The quick ratio has soared by 133% YoY but it has decreased by 14% QoQ
SRXH's current ratio has soared by 76% YoY but it is down by 12% QoQ
SRXH's debt is 71% smaller than its equity
The company's equity has surged by 190% YoY but it fell by 16% QoQ
The debt to equity has dropped by 82% year-on-year but it is up by 45% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.